Xenon Pharmaceuticals XENE
NASDAQ XENE
$35.24 -1.26 (-3.44%)
As of: Oct 23, 2026 · 3:59 PM EDT

Xenon Pharmaceuticals (XENE) Amortization of Deferred Charges (2018 - 2020)

Updated

Analysis

Xenon Pharmaceuticals (XENE) Amortization of Deferred Charges (2018 - 2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Xenon Pharmaceuticals 3.53 Bn 493.58 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2020 79,000.00
Mar 31, 2020 137,000.00
Dec 31, 2019 137,000.00
Sep 30, 2019 133,000.00
Jun 30, 2019 130,000.00
Mar 31, 2019 125,000.00
Dec 31, 2018 128,000.00
Sep 30, 2018 -8,000.00
Jun 30, 2018 92,000.00
Mar 31, 2018 72,000.00
API Access

Xenon Pharmaceuticals Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=XENE&period=max&api_key=YOUR_API_KEY